HOOK251017P00005000 Option on Hookipa Pharma

HOOK Stock  USD 0.97  0.07  6.73%   
HOOK251017P00005000 is a PUT option contract on Hookipa Pharma's common stock with a strick price of 5.0 expiring on 2025-10-17. The contract was not traded in recent days and, as of today, has 86 days remaining before the expiration. The option is currently trading at a bid price of $2.95, and an ask price of $4.3. The implied volatility as of the 23rd of July is 86.0.
When exercised, put options on Hookipa Pharma produce a short position in Hookipa Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Hookipa Pharma's downside price movement.

Rule 16 of 2025-10-17 Option Contract

The options market is anticipating that Hookipa Pharma will have an average daily up or down price movement of about 0.23% per day over the life of the option. With Hookipa Pharma trading at USD 0.97, that is roughly USD 0.00222. If you think that the market is fully understating Hookipa Pharma's daily price movement you should consider buying Hookipa Pharma options at that current volatility level of 3.66%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

In The Money Put Option on Hookipa Pharma

An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Hookipa Pharma positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Hookipa Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Put Contract NameHOOK251017P00005000
Expires On2025-10-17
Days Before Expriration86
Vega0.001875
Gamma0.23454
Theoretical Value4.3
Open Interest4
Strike Price5.0
Last Traded At3.6
Current Price Spread2.95 | 4.3
Rule 16 Daily Up or DownUSD 0.00222

Hookipa short PUT Option Greeks

Hookipa Pharma's Option Greeks for the contract ending on 2025-10-17 at a strike price of 5.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Hookipa Pharma's option greeks, its implied volatility helps estimate the risk of Hookipa Pharma stock implied by the prices of the options on Hookipa Pharma's stock.
Delta-0.515378
Gamma0.23454
Theta-0.003613
Vega0.001875
Rho-0.006681

Hookipa long PUT Option Payoff at expiration

Put options written on Hookipa Pharma grant holders of the option the right to sell a specified amount of Hookipa Pharma at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Hookipa Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Hookipa Pharma is like buying insurance aginst Hookipa Pharma's downside shift.
   Profit   
       Hookipa Pharma Price At Expiration  

Hookipa short PUT Option Payoff at expiration

By selling Hookipa Pharma's put option, the investors signal their bearish sentiment. A short position in a put option written on Hookipa Pharma will generally make money when the underlying price is above the strike price. Therefore Hookipa Pharma's put payoff at expiration depends on where the Hookipa Stock price is relative to the put option strike price. The breakeven price of 0.7 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Hookipa Pharma's price. Finally, at the strike price of 5.0, the payoff chart is constant and positive.
   Profit   
       Hookipa Pharma Price At Expiration  
View All Hookipa Pharma Options

Hookipa Pharma Available Put Options

Hookipa Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Hookipa. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Hookipa. It also shows strike prices and maturity days for a Hookipa Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
 Put
HOOK251017P0000750007.54.3 - 8.95.74In
 Put
HOOK251017P0000500045.02.95 - 4.33.6In
 Put
HOOK251017P0000250002.50.0 - 1.61.5In

Hookipa Pharma Corporate Management

When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.85)
Revenue Per Share
0.747
Quarterly Revenue Growth
(0.94)
Return On Assets
(0.45)
Return On Equity
(1.06)
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.